首页> 美国卫生研究院文献>Epidemiology and Infection >An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species.
【2h】

An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species.

机译:SAD B19狂犬病病毒疫苗针对目标和非目标物种的安全性研究的最新进展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

SAD B19 is an attenuated vaccine virus for oral vaccination of carnivores against rabies. The safety of SAD B19 was investigated in 16 animal species by different routes of administration. During the observation period all animals given the vaccine virus, irrespective of the route of administration, did not show any clinical signs of rabies, with the exception of certain rodent species. In these animals a low residual pathogenicity was observed, however transmission of the vaccine virus to control animals was not demonstrable. No vaccine virus could be detected in the saliva of the six mammal species examined. Furthermore, the genetical stability was shown for SAD B19 through passaging in neural tissue of dogs, foxes and mice. From the results presented here on innocuity and stability, it can be concluded that SAD B19 rabies vaccine is suitable for oral vaccination campaigns for carnivores against rabies.
机译:SAD B19是一种减毒疫苗病毒,用于口服食肉狂犬病疫苗。通过不同的给药途径研究了16种动物中SAD B19的安全性。在观察期间,除某些啮齿类动物外,所有给予疫苗病毒的动物,不论给药途径如何,均未显示出狂犬病的任何临床体征。在这些动物中观察到了较低的残留致病性,但是尚不能证明疫苗病毒向对照动物的传播。在所检查的六个哺乳动物物种的唾液中未检测到疫苗病毒。此外,通过在狗,狐狸和小鼠的神经组织中传代,显示出SAD B19的遗传稳定性。从此处提供的关于纯真度和稳定性的结果可以得出结论,SAD B19狂犬病疫苗适用于针对狂犬病的食肉动物的口服疫苗接种运动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号